In 1998, the medical landscape experienced a seismic shift. A new molecule was introduced to the public that fundamentally altered how we understand aging, blood flow, and male vitality. Before this point, localized vascular decline was largely dismissed as an inevitable, untreatable psychological consequence of getting older. Today, we recognize i